Smith & Nephew plc (LON:SN)
1,337.00
-5.00 (-0.37%)
Oct 7, 2025, 5:29 PM BST
Smith & Nephew Revenue
Smith & Nephew had revenue of $2.96B USD in the half year ending June 28, 2025, with 8.30% growth. This brings the company's revenue in the last twelve months to $5.94B, up 5.35% year-over-year. In the year 2024, Smith & Nephew had annual revenue of $5.81B with 4.70% growth.
Revenue (ttm)
$5.94B
Revenue Growth
+5.35%
P/S Ratio
2.65
Revenue / Employee
$342.61K
Employees
17,349
Market Cap
11.47B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.81B | 261.00M | 4.70% |
Dec 31, 2023 | 5.55B | 334.00M | 6.40% |
Dec 31, 2022 | 5.22B | 3.00M | 0.06% |
Dec 31, 2021 | 5.21B | 652.00M | 14.30% |
Dec 31, 2020 | 4.56B | -578.00M | -11.25% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
HUTCHMED (China) | 439.54M |
Genus | 672.80M |
Oxford Nanopore Technologies | 204.69M |
Smith & Nephew News
- 4 days ago - Smith+Nephew announce latest scientific data supporting new ALLEVYN™ COMPLETE CARE 5-Layer Foam Dressing for pressure injury prevention - GlobeNewsWire
- 6 days ago - Smith+Nephew launches CORIOGRAPH™ Pre-Op Planning and Modeling Services for total shoulder arthroplasty - GlobeNewsWire
- 6 days ago - Ex-Dividend Reminder: ESAB, Sylvamo and Smith & Nephew - Nasdaq
- 6 days ago - Smith & Nephew Reaches Analyst Target Price - Nasdaq
- 7 days ago - Smith & Nephew (SNN) CFO Relocates to U.S. to Drive Growth - GuruFocus
- 7 days ago - Smith & Nephew CFO shifts base to U.S. from U.K. - Seeking Alpha
- 22 days ago - Smith & Nephew (SNN) Upgraded to Buy: What Does It Mean for the Stock? - Nasdaq
- 26 days ago - Smith+Nephew (SNN) Highlights Advances in REGENETEN Implant Technology - GuruFocus